Christof C.W. Verlackt (Belgium) made his PhD from 2013 till 2018, on modelling of the interactions of reactive oxygen species with biomolecules (DNA, sugars, amino acids, peptides) by means of molecular dynamics simulations (classical MD and DFTB), as well as modelling of the transport and accumulation of plasma species in liquid answer (plasma-liquid interaction), for medical purposes. Another key strength of Karebay is natural chemistry (e.g. fluorophore chemistry), resolution part chemistry, polymer chemistry, nanoparticles, moreover the nicely-known strong part peptide chemistry. The founder, Drew Dai did his artificial chemistry, as a part of his PHD dissertation at Univ. Jinxin Wang (P.R. China) did his PhD from 2018 till 2023, on catalyst synthesis and plasma catalysis for dry reforming of methane, beneath joint supervision of V. Meynen (LADCA) and A. Bogaerts. He studied the CO2 conversion in a packed bed dielectricbarrier discharge, by a mix of plasma and catalysis. Yanhui Yi (P.R. China) labored in our group as a postdoc from 2018 till 2020, on plasma catalysis for the conversion of small molecules into clear vitality and value-added chemicals.
Another misunderstanding is that most people feel that the number of enzymes/ribozymes, let alone the ribozymal RNA polymerases or any type of self-replicator, signify a really unlikely configuration and that the possibility of a single enzyme/ribozyme forming, not to mention various them, from random addition of amino acids/nucleotides is very small. KareBay has been with small compound custom synthesis enterprise for six years, inside yearly manufacturing capacity over 1 ,000 small compounds; production scales from mg up to Kilograms; Karebay has been serving most of prestigious institutes and universities on this planet. In response to data from the European Commission and the World Health Organization, diseases like cancer and cardiovascular ailments proceed to afflict millions, emphasizing the need for the development of recent medication, especially in high-finish therapeutic areas. Depending on the peptide and its intended use, your healthcare provider could suggest regular monitoring of certain well being parameters, such as hormone levels or blood markers. He did analysis in our group from 2016 until 2017, in collaboration with the center for Oncological Research (CORE; E. Smits) of the Faculty of Medicine and Health Sciences, on plasma remedy of liquids, to be used for cancer cell treatment.
Hanne Verswyvel (Belgium) did her PhD in our plasma-onco group (joint group with the center for Oncological Research, CORE) from 2020 until 2025, on evaluating the immunogenic and therapeutic potential of non-thermal plasma in head and neck cancer. Ruben Verloy (Belgium) made his PhD in our group from 2020 till 2025, on dose dependent effects of plasma treatment in 2D pancreatic cancer fashions, as a joint PhD pupil with the middle for Oncological Research (CORE; E. Smits). Kevin van ‘t Veer (the Netherlands) made his PhD in our group from 2018 till 2022, on modeling NH3 formation by DBD plasma and plasma catalysis, , as a joint PhD student with Université Libre de Bruxelles (F. Wesley Somers (Belgium) made his PhD in our group within the period 2011-2015. He performed classical molecular dynamics simulations of hydrocarbon species interacting with Ni-surfaces in the context of plasma catalysis, using the ReaxFF potential. Laurent Schwaederlé (France) labored for 1 yr in our group as a postdoc, on magnetron modelling (i.e., calculations of magnetic area strength, as well as electron Monte Carlo modelling), in collaboration with Ghent University where he performed some validation experiments.
Andrew Sandeman (UK) labored in our group as a postdoc for about 1 year (2023-2024), on chemical kinetics modeling of H2 synthesis from NH3 plasmas. Jintao Sun (P.R. China) worked in our group for 1 yr (2021-2022) within the framework of his PhD at Beijing Jiaotong University. Surong Sun (P.R. China) was working in our group for 2 years (2016-2018), in the framework of her PhD at Beijhang University (double doctorate). Quan-Zhi Zhang (P.R. China) labored in our group for six months in 2013-2014 (within the framework of his double doctorate between our university and Dalian University of Technology), as well as for three years (2016-2019) as a postdoc, with a H2020 MSCA postdoc fellowship, focussing on modelling for cryogenic plasma etching. She was modelling a gliding arc for CO2 conversion. Koen Van Laer (Belgium) made his PhD in our group from 2012 till 2017, on modelling and experiments in a packed bed dielectric barrier discharge, used for CO2 conversion. Bart Wanten (Belgium) made his PhD in our group from 2020 to 2024, on experiments for plasma-based mostly CO2 and CH4 conversion in atmospheric stress glow discharge plasma, together with the results of O2 or H2O vapor addition.
Leave a Reply